What Has GLP-1 In It? Weight Loss Agonists Explained

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 (GLP-1) agonists have emerged as a breakthrough category in weight management, with clinical studies showing average weight loss of 10-15% of body weight over 68 weeks. These medications work by activating GLP-1 receptors in your brain and digestive system, signaling fullness and reducing hunger. Understanding what GLP-1 medications contain and how they function is the first step toward choosing the right personalized therapy for your goals.

What Exactly Is GLP-1 and How Does It Work in Your Body?

GLP-1 is a natural hormone your intestines release when you eat food, particularly nutrients like glucose and amino acids. This hormone travels to your brain and pancreas, where it slows stomach emptying, increases feelings of satiety, and helps regulate blood sugar levels. By mimicking this process, GLP-1 agonist medications recreate the body's own appetite-suppression system without requiring dietary restriction alone.

When GLP-1 agonists activate receptors along your gastrointestinal tract and in your hypothalamus, they reduce cravings and portion sizes by making you feel fuller on less food. This mechanism operates independently of willpower or calorie counting, addressing the biological roots of overeating rather than treating it as a behavioral problem. The result is sustained weight loss that works with your body's natural signals rather than against them.

Medications That Contain GLP-1 Agonists: Semaglutide and Tirzepatide

Semaglutide is a synthetic GLP-1 agonist available in both injectable and oral formulations, originally developed to address elevated blood glucose in type 2 diabetes before its weight management benefits became widely recognized. PlexusDx compounded semaglutide injection starts at $149 per month and delivers consistent GLP-1 activation throughout the week. Oral semaglutide offers a needle-free alternative at $249 per month, though injectable versions typically produce faster and more reliable absorption.

Tirzepatide is a dual GLP-1 and GIP receptor agonist—meaning it activates two hormone pathways simultaneously for enhanced weight loss compared to single-agent GLP-1 therapy. PlexusDx compounded tirzepatide injection begins at $249 per month, while the oral version starts at $279 per month. For patients seeking maximum versatility, PlexusDx GLP-Squared combines both semaglutide and tirzepatide in a single injection or oral protocol, starting at $249 and $369 monthly respectively.

GLP-1 Compounded Medications vs. Brand-Name Options: Key Differences

PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which are regulated by state boards of pharmacy and the FDA to ensure sterility, potency, and quality control. While brand-name GLP-1 products like Ozempic and Saxenda carry FDA approval, compounded versions from 503A facilities offer equivalent active ingredients at significantly lower out-of-pocket costs. The distinction matters because 503A compounders must follow strict guidelines—including USP standards and regular third-party testing—to guarantee medication safety and consistency.

Compounded GLP-1 medications contain the same active pharmaceutical ingredients as brand-name counterparts but avoid the markup associated with branded marketing and distribution networks. This cost savings applies to all income levels because PlexusDx accepts no insurance requirements, membership fees, or hidden charges—just a flat monthly rate. HSA and FSA accounts are eligible for PlexusDx medications, further reducing your net out-of-pocket expense.

Personalized GLP-1 Selection: The Role of Genetic Testing in Your Treatment

Not all GLP-1 agonists work equally well for every person—your genetic makeup influences how strongly you respond to semaglutide, tirzepatide, or combination therapy. PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways across 49 peptides and 150+ genetic insights, including key variants like GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. This peptide-pathway genetic analysis helps PlexusDx identify whether you're a strong responder to GLP-1 alone, a better candidate for dual-receptor therapy, or someone who may benefit from the microdose protocol.

Your genetic profile directly informs which medication—semaglutide injection ($149/mo), tirzepatide injection ($249/mo), GLP-Squared combination ($249/mo injection or $369/mo oral), or the Microdose GLP-1 Protocol ($129/mo)—will deliver the fastest and most sustainable results for your metabolism. This precision-medicine approach eliminates months of trial-and-error adjustments by predicting your likely response before you start. PlexusDx handles dosage optimization without price increases, honoring the principle that your dose may need to go up but your price won't.

Side Effects and Safety: What GLP-1 Medications May Cause

The most common side effects of GLP-1 agonists are gastrointestinal—nausea, vomiting, diarrhea, and constipation—which typically emerge during dose escalation and diminish as your body adapts within 2-4 weeks. These effects occur because GLP-1 activation slows gastric emptying and increases gut motility, mimicking the sensation of having eaten a large meal. Staying hydrated, eating small frequent meals, and avoiding fatty or greasy foods substantially reduces nausea incidence.

Serious adverse events are rare but include acute pancreatitis, gallbladder disease, and kidney complications in patients with pre-existing conditions. PlexusDx requires a brief medical history review before dispensing to identify contraindications, and all medications ship with comprehensive safety information. If you experience severe abdominal pain, persistent vomiting, or changes in kidney function, contact your healthcare provider immediately and discontinue use until evaluated.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does PlexusDx semaglutide contain the exact same active ingredient as Ozempic or Wegovy?

Yes—PlexusDx compounded semaglutide contains identical synthetic GLP-1 agonist molecules as brand-name versions, produced by licensed 503A compounding pharmacies under strict quality control.

What clinical evidence supports GLP-1 agonists for weight loss?

Multiple large randomized trials demonstrate GLP-1 agonists produce 10–15% average body weight loss over 68 weeks, with some patients achieving 20%+ reductions. Tirzepatide (dual GLP-1/GIP agonist) shows superior results to semaglutide alone in head-to-head studies, which is why PlexusDx offers both options and combination therapy.

How much does PlexusDx semaglutide cost, and does the price change as my dose increases?

PlexusDx semaglutide injection starts at $149 per month on the lowest commitment tier and remains flat across all dose levels—your dose may need to go up, but your price won't. Higher commitment tiers max out at $189 monthly. Oral semaglutide begins at $249 per month, also dose-flat.

Are compounded GLP-1 medications from PlexusDx as safe as FDA-approved brands?

PlexusDx sources all medications from licensed 503A compounding pharmacies, which must meet state pharmacy board standards and FDA regulations for sterility and potency. While compounded medications are not FDA-approved as finished products, 503A pharmacies maintain equivalent safety protocols.

How can the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

The Precision Peptide Genetic Test ($99 after your first treatment month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to predict your individual response pattern.

What Has GLP-1 In It? Understanding GLP-1 Agonists and Their Role in Weight Management